Skip to content
healthcare.dev

Aralast NP

NDC 0944-2814, Alpha-1-Proteinase Inhibitor (Human), kit, from Takeda Pharmaceuticals America, Inc..

Product NDC
0944-2814
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
KIT
Route
—
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125039
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
0944-2814-01009442814011 KIT in 1 CARTON (0944-2814-01) * 25 mL in 1 VIAL, GLASS (64764-518-25) * 25 mL in 1 VIAL (0944-2803-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0944-2814

Use it

Look up 0944-2814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0944-2814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0944-2814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.